EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing

Kinder mit Diabetes und mindestens einem nicht-autoimmunen Merkmal sollten für eine Testung auf monogene Diabetesformen erwogen werden

Rebecca Myers iD, Melek Yildiz iD, Mehmet Nuri Ozbek, Jaida Manzoor, Mohsina Ibrahim, Chittaranjan Yajnik, Muge Atar, Zeynep Şiklar, Sezer Acar iD, Evgenia Globa, Omneya Magdy Omar, Huseyin Demirbilek und 12 weitere

The Journal of Clinical Endocrinology & Metabolism · 21.01.2026 · 111 (2) · e362-e367

DOI: 10.1210/clinem/dgaf430 ↗

Auf einen Blick

Bei 183 Kindern mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal wurden bei 33 % monogene Diabetesformen gefunden. Islet-Antikörper und T1DGRS halfen bei der Priorisierung der Testung.

Fragestellung

Sollten bei Kindern mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal alle auf monogene Diabetesformen getestet werden?

Methode

183 Kinder mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal; Bestimmung von Islet-Antikörpern und T1DGRS; zielgerichtete Next-Generation-Sequenzierung aller bekannten Ursachen monogener Diabetesformen.

Ergebnisse

33 % (61/183) hatten bestätigten monogenen Diabetes. 84 % (51/61) waren rezessiv; häufig waren WFS1 (46 %), SLC19A2 (12 %) und SLC29A3 (12 %).

Schlussfolgerung der Autor:innen

Kinder mit Diabetes und mindestens einem nicht-autoimmunen extra-pankreatischen Merkmal sollten für eine Testung auf monogene Diabetesformen erwogen werden. Islet-Antikörper und T1DGRS helfen, genetische Tests zu priorisieren.

Kernaussagen

  • 33 % (61/183) hatten bestätigten monogenen Diabetes
  • 84 % der monogenen Fälle hatten rezessive Ursachen
  • Islet-Antikörper und T1DGRS halfen bei der Priorisierung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.08.2025. Verfasst von Rebecca Myers und 23 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical and Clinical Science, University of Exeter, Exeter EX2 5DW, UK. Hauptthemen laut MEDLINE: Genetic Testing, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Diabetes UK, Wellcome Trust Senior Investigator.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Monogenic diabetes testing in children currently targets maturity onset diabetes in the young (MODY) or recognized genetic syndromes.

Objective

We aim to determine whether genetic testing for monogenic diabetes should be performed for all children with diabetes and at least one non-autoimmune extra-pancreatic feature (syndromic diabetes).

Methods

We recruited 183 children with diabetes and at least one non-autoimmune extra-pancreatic feature (50% [n = 91] with self-reported consanguinity). We measured islet-autoantibodies and type 1 diabetes (T1D) genetic risk score (T1DGRS) and used targeted next-generation sequencing to analyze all known causes of monogenic diabetes.

Results

Of the children, 33% (61/183) had confirmed monogenic diabetes. Of these, 84% (51/61) had recessive etiologies with variants in WFS1 (46%), SLC19A2 (12%) and SLC29A3 (12%) being most common. Monogenic cases compared to non-monogenic had similar age of diagnosis (7.4 vs 6, P = .1) and body mass index z-score (−0.08 vs −0.41, P = .3) but had higher parental consanguinity (62% vs 19%, P = .01) and features in multiple organ systems (53% vs 28%, P = .01). Only 59% reported well-recognized features of their associated genetic syndrome. Children with low T1DGRS (<50th centile of T1D population) and negative/untested antibodies were more likely to have monogenic cause compared to positive antibodies or negative/untested antibodies and a high T1DGRS (≥ 50th centile) (48% vs 3% vs 7%, P < .0001).

Conclusion

Children with diabetes and at least one non-autoimmune extra-pancreatic feature should be considered for monogenic diabetes testing. Measurement of islet-autoantibodies and T1DGRS help prioritize genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingDiabetes Mellitus, Type 1HumansChildFemaleMaleAdolescentChild, PreschoolAutoantibodiesGenetic Predisposition to Disease

Stichwörter der Autor:innen

diabetesgenetic testingmonogenic diabetespediatricssyndromic diabetes

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Institute of Biomedical and Clinical Science, University of Exeter, Exeter EX2 5DW, UK.
  • Department of Pediatric Endocrinology, Istanbul University Faculty of Medicine, 34093 Istanbul, Turkey.
  • Department of Paediatric Endocrinology, Gazi Yasargil Diyarbakir Training and Research Hospital, 21100 Diyarbakir, Turkey.
  • Department of Pediatric Endocrinology and Diabetes, Children's Hospital, University of Child Health Sciences, Lahore 54600, Pakistan.
  • National Institute of Child Health, Paediatric Endocrinology and Diabetes Department, Karachi 75510, Pakistan.
  • Department of Diabetes, King Edward Memorial Hospital & Research Centre, Pune 411011, India.

ORCID-Profile: Rebecca Myers, Melek Yildiz, Sezer Acar, Korcan Demir, Andrew Hattersley, Kashyap Patel

Förderung

  • Wellcome Trust
  • Diabetes UK
  • Wellcome Trust Senior Investigator

Zitieren

APA

Myers, R., Yildiz, M., Nuri Ozbek, M., Manzoor, J., Ibrahim, M., Yajnik, C., Atar, M., Şiklar, Z., Acar, S., Globa, E., Magdy Omar, O., Demirbilek, H., Hassan, S., Demir, K., Hanif, M., Guran, T., Hatipoglu, N., Koçyiğit, C., Colclough, K., …, & Monogenic Diabetes Consortium (2026). Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing. The Journal of Clinical Endocrinology & Metabolism, 111(2), e362-e367. https://doi.org/10.1210/clinem/dgaf430

Vancouver

Myers R, Yildiz M, Nuri Ozbek M, Manzoor J, Ibrahim M, Yajnik C, et al. Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing. The Journal of Clinical Endocrinology & Metabolism. 2026;111(2):e362-e367. doi:10.1210/clinem/dgaf430

BibTeX
@article{Myers2026,
  author = {Myers, Rebecca and Yildiz, Melek and Nuri Ozbek, Mehmet and Manzoor, Jaida and Ibrahim, Mohsina and Yajnik, Chittaranjan and Atar, Muge and Şiklar, Zeynep and Acar, Sezer and Globa, Evgenia and Magdy Omar, Omneya and Demirbilek, Huseyin and Hassan, Samar and Demir, Korcan and Hanif, Misbah and Guran, Tulay and Hatipoglu, Nihal and Koçyiğit, Cemil and Colclough, Kevin and Houghton, Jayne and Hattersley, Andrew and Van Heugten, Rachel and Patel, Kashyap and Monogenic Diabetes Consortium, Monogenic Diabetes Consortium},
  title = {Children With Diabetes and At Least One Non-Autoimmune Feature Should Be Considered for Monogenic Diabetes Testing},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  volume = {111},
  number = {2},
  pages = {e362--e367},
  doi = {10.1210/clinem/dgaf430}
}
Kostenlos starten →